SCHEMBL2410992

SCHEMBL2410992

O=C(NO)c1ccc(CCNS(=O)(=O)c2ccc(F)c(F)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC2 Q92769 1/20 0.59
MAPT P10636 4/20 0.51
LMNA P02545 3/20 0.51
KMT2A Q03164 2/20 0.51
TP53 P04637 2/20 0.51
MEN1 O00255 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
AKR1C3 P42330 2/20 0.49
PRMT1 Q99873 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPK1 P28482 1/20 0.48
HDAC3 O15379 1/20 0.48
RECQL P46063 1/20 0.48
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2411710 0.83 PRMT1 (0.68) HDAC6HDAC8HDAC2MAPTKMT2A
SCHEMBL2413993 0.81 HDAC6 (0.58) HDAC6HDAC8HDAC2MAPTLMNA
SCHEMBL2410791 0.80 HDAC6 (0.51) HDAC6HDAC8HDAC2MAPTLMNA
SCHEMBL2407780 0.76 HDAC6 (0.52) HDAC6HDAC8HDAC2MAPTKMT2A
SCHEMBL2941910 0.73 ALDH1A1 (0.59) MAPTLMNAKMT2ANPSR1TBXA2R
SCHEMBL2406521 0.72 SLC1A3 (0.47) HDAC6HDAC8MAPTLMNAKMT2A
SCHEMBL14485055 0.72 MAPT (0.80) MAPTLMNAKMT2ATP53MEN1
SCHEMBL2408423 0.71 HDAC8 (0.47) HDAC6HDAC8HDAC2MAPTLMNA
SCHEMBL10462381 0.71 CYP1A2 (0.72) MAPTKMT2AMEN1NPSR1CA1
SCHEMBL16404773 0.71 HDAC6 (0.67) HDAC6HDAC8HDAC2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106632-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 WO disclosed